Abstract Within a double-blind, cross-around trial, triazolam (0.25 mg) was examined towards flunitrazepam (1 mg) in the typical midwinter sleeplessness which is normally found among in any other case healthier persons in Northern Norway. Every drug was provided for five nights, in random buy, which has a five-night placebo interval amongst the Liv